Brisk clinical response to erythrocytapheresis in a G6PD‐deficient patient with rasburicase‐induced methemoglobinemia
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Apheresis"
DOI: 10.1002/jca.21540
Abstract: Dear Editor, We read with interest the recent report by Montgomery and Booth, who described a case of methemoglobinemia in a 50-year-old, G6PD-deficient African American man with newly diagnosed T-cell lymphoblastic leukemia being treated with… read more here.
Keywords: range; rasburicase; methemoglobinemia; g6pd deficient ... See more keywords
Aggressive lymphoma, hemophagocytic lymphohistiocytosis, and G6PD crisis: a lytic cocktail
Sign Up to like & getrecommendations! Published in 2021 at "Annals of Hematology"
DOI: 10.1007/s00277-021-04410-5
Abstract: Dear Editor, We report a case of aggressive lymphoma that received corticosteroids without tumoral lysis prevention and then salvage therapy with rasburicase, inducing glucose-6-phosphate dehydrogenase (G6PD) crisis. A 19-year-old male, originating from Madagascar, was admitted… read more here.
Keywords: aggressive lymphoma; g6pd; rasburicase; g6pd crisis ... See more keywords
Rasburicase in hemolytic uremic syndrome related to Shiga toxin-producing Escherichia coli: a report of nine cases
Sign Up to like & getrecommendations! Published in 2020 at "Pediatric Nephrology"
DOI: 10.1007/s00467-020-04528-0
Abstract: Background Hyperuricemia might induce additional renal damage in children with hemolytic uremic syndrome related to Shiga toxin-producing Escherichia coli (STEC-HUS). A few case reports have shown rasburicase to be effective in decreasing serum uric acid… read more here.
Keywords: uremic syndrome; rasburicase; syndrome related; related shiga ... See more keywords
A new form of inherited thrombocytopenia due to monoallelic loss of function mutation in the thrombopoietin gene
Sign Up to like & getrecommendations! Published in 2018 at "British Journal of Haematology"
DOI: 10.1111/bjh.14694
Abstract: Cairo, M.S. & Bishop, M. (2004) Tumour lysis syndrome: new therapeutic strategies and classification. British Journal of Haematology, 127, 3–11. Coiffier, B., Mounier, N., Bologna, S., Ferm e, C., Tilly, H., Sonet, A., Christian, B.,… read more here.
Keywords: lysis syndrome; tumour lysis; rasburicase; journal ... See more keywords
Rasburicase‐induced methaemoglobinaemia and catastrophic oxidative haemolysis in undiagnosed G6PD deficiency
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Haematology"
DOI: 10.1111/bjh.18464
Abstract: A 56yearold man of Kurdish/Iraqi descent was diagnosed with Tcell prolymphocytic leukaemia (left, ×100 objective) and planned for treatment with alemtuzumab. He was given rasburicase for prevention of tumour lysis syndrome. Unfortunately, glucose6phosphate dehydrogenase (G6PD)… read more here.
Keywords: oxidative haemolysis; rasburicase; haemolysis; g6pd deficiency ... See more keywords
Rasburicase-induced haemolysis and methemoglobinemia: an ongoing issue
Sign Up to like & getrecommendations! Published in 2021 at "BMJ Case Reports"
DOI: 10.1136/bcr-2020-240967
Abstract: We report a case of a 91-year-old Caucasian woman with a history of chronic lymphocytic leukaemia who developed acute hypoxic respiratory failure (AHRF) requiring intubation for less than 24 hours after receiving rasburicase. Laboratory workup… read more here.
Keywords: induced haemolysis; rasburicase; g6pd deficiency; rasburicase induced ... See more keywords
Single 4.5 mg fixed-dose of rasburicase for hyperuricemia associated with tumor lysis syndrome
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155216644975
Abstract: Rasburicase is a recombinant urate oxidase enzyme administered for treatment of hyperuricemia associated with tumor lysis syndrome. Studies demonstrate effectiveness of single fixed-dose rasburicase as compared to the FDA-approved dose of 0.2 mg/kg intravenously daily for… read more here.
Keywords: uric acid; single fixed; rasburicase; dose rasburicase ... See more keywords
Comparative Effectiveness of Rasburicase Versus Allopurinol for Cancer Patients with Renal Dysfunction and Hyperuricemia
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-124058
Abstract: Introduction: While rasburicase has shown efficacy to rapidly correct hyperuricemia compared with allopurinol, its overall impact in improving clinically significant outcomes in tumor lysis syndrome (TLS) is unknown. There are no studies demonstrating improvement of… read more here.
Keywords: renal dysfunction; creatinine; rasburicase; versus ... See more keywords
Healthcare Resource Utilization with Rasburicase in the Management of Patients with Tumor Lysis in the Outpatient Setting: Results from a Community Oncology Cohort
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-125922
Abstract: BACKGROUND and OBJECTIVE: Tumor lysis syndrome (TLS), a potentially fatal oncologic complication, can have a significant clinical and economic impact to patients and the healthcare system. The aim of this analysis was to examine healthcare… read more here.
Keywords: utilization; outpatient setting; rasburicase; cost ... See more keywords
Survey of Anaphylaxis during Rasburicase Re-Administration in Patients with Hematological Malignancies Using a Japanese Claims Database
Sign Up to like & getrecommendations! Published in 2022 at "Current Oncology"
DOI: 10.3390/curroncol29120772
Abstract: Management of tumor lysis syndrome (TLS) associated with cancer chemotherapy for malignant tumors is important because of its potentially fatal course. The use of rasburicase, a recombinant urate oxidase, is recommended for TLS; however, because… read more here.
Keywords: administration patients; administration; rasburicase administration; rasburicase ... See more keywords